US news
fromwww.npr.org
3 hours agoHow a Supreme Court fight over fish oil could raise your prescription drug costs
The U.S. benefits from low prices on generic drugs, but brand-name monopolies delay access to these savings.
This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice on modifying patent term adjustment practices;
Released last month, the study finds that nearly half of U.S. adults worry they won't be able to afford necessary medical care in the coming year, and one in five households reported being unable to pay for prescription medicine in the past three months. Another sobering point: about three in ten U.S. adults said that someone in their household went without needed medical care in the past year because they just couldn't afford it.